Lexeo Therapeutics (LXEO) Enterprise Value (2022 - 2026)
Lexeo Therapeutics recorded quarterly Enterprise Value of -$193.0 million in Q1 2026, down 6.2% quarter-over-quarter from -$181.8 million in Q4 2025, and down 93.37% year-over-year from -$2.9 billion in Q1 2025.
Lexeo Therapeutics' Enterprise Value history runs 5 years deep, the most recent figure standing at -$193.0 million for Q1 2026.
- In Q1 2026, Enterprise Value fell 93.37% year-over-year to -$193.0 million; the TTM figure through Mar 2026 stood at -$193.0 million (down 93.37% YoY), while the FY2025 annual figure was -$181.8 million, down 49.58% from the prior year.
- Enterprise Value came in at -$193.0 million for Q1 2026 at Lexeo Therapeutics, down from -$181.8 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$35.4 million in Q3 2023 to a low of -$195.1 million in Q1 2024.
- A 5-year average of -$131.3 million and a median of -$122.8 million in 2025 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value soared 62.35% in 2023 and slumped 342.89% in 2024, its largest moves.
- Lexeo Therapeutics' Enterprise Value stood at -$77.3 million in 2022, then tumbled by 57.06% to -$121.5 million in 2023, then decreased by 0.04% to -$121.5 million in 2024, then plunged by 49.58% to -$181.8 million in 2025, then retreated by 6.2% to -$193.0 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$193.0 million, -$181.8 million, and -$122.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Lexeo Therapeutics | 392.12 Mn | 199.07 Mn | - | -193.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -193.04 Mn |
| Dec 31, 2025 | -181.77 Mn |
| Sep 30, 2025 | -122.76 Mn |
| Jun 30, 2025 | -132.89 Mn |
| Mar 31, 2025 | -99.83 Mn |
| Dec 31, 2024 | -121.52 Mn |
| Sep 30, 2024 | -157.00 Mn |
| Jun 30, 2024 | -175.00 Mn |
| Mar 31, 2024 | -195.10 Mn |
| Dec 31, 2023 | -121.47 Mn |
| Sep 30, 2023 | -35.45 Mn |
| Dec 31, 2022 | -77.34 Mn |
| Sep 30, 2022 | -94.15 Mn |